Search

everythinglearnresearchcommunity

for

Search:↓

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Finasteride may not affect gynecomastia recurrence after mastectomy.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

A group has developed therapies that show promise for treating cancer and various other conditions.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.